Investment
Features
FeesSafety
Academy
More
Pluang+

FibroBiologics secures European patent for enhanced fibroblast therapy targeting spinal disc regeneration.

Company Fundamentals
29 Sep 2026
PRNewsWire
View Source
Bullish
FibroBiologics secures European patent for enhanced fibroblast therapy targeting spinal disc regeneration.

FibroBiologics announced that the European Patent Office granted them a patent for methods that enhance fibroblast cells using platelet rich plasma and cytokines to improve tissue regeneration, including spinal disc repair. This innovation targets chronic lower back pain by promoting anti-inflammatory and regenerative properties in fibroblasts, potentially offering a biological treatment alternative to surgery. The patent strengthens FibroBiologics' intellectual property portfolio and supports their ongoing clinical programs for disc degeneration and other chronic diseases. This development could advance new therapies for conditions that have been difficult to treat biologically.

FibroBiologics patent news offers context for health-sector stocks on Pluang. For readers following health stocks, 50 of 100 US health-sector stocks rose and 41 fell as of Sep 29, 2026 19:14 WIB. Notable movers include SANA at USD 2.99 (+2.05%), ADPT at USD 29.06 (+1.93%), and CYTK at USD 67.24 (+1.63%).

More News

Kayne Anderson Energy Infrastructure Fund offers 8.1% yield with strong NAV growth but trades at a 12.13% discount.

Kayne Anderson Energy Infrastructure Fund offers 8.1% yield with strong NAV growth but trades at a 12.13% discount.

The Kayne Anderson Energy Infrastructure Fund (KYN) is a closed-end fund focused on North American energy infrastructure, particularly midstream companies. It currently trades at a 12.13% discount to its net asset value (NAV) and offers an 8.1% yield...

Analyst Insights
Bullish
4 hours ago
US home prices rise 1.9% YoY in July 2026 despite 14 months of real-term declines amid inflation.

US home prices rise 1.9% YoY in July 2026 despite 14 months of real-term declines amid inflation.

In July 2026, the S&P Cotality Case-Shiller U.S. National Home Price Index showed a 1.9% annual increase, up from 1.6% in June, marking continued nominal home price growth despite 14 consecutive months of real-term declines due to inflation outpacing...

Market News
Neutral
4 hours ago
Bitcoin may face selling pressure after 2026 US midterms, following historical post-election declines.

Bitcoin may face selling pressure after 2026 US midterms, following historical post-election declines.

Crypto analyst Ali Martinez highlighted that Bitcoin historically dropped significantly after US midterm elections, with declines of 72%, 65%, 52%, and 27% following the 2010, 2014, 2018, and 2022 elections respectively. While this pattern doesn't pr...

Analyst Insights
Bearish
4 hours ago
UnitedHealth stock stagnant for 5 years, but dividends steadily rose, offering steady income despite cost challenges.

UnitedHealth stock stagnant for 5 years, but dividends steadily rose, offering steady income despite cost challenges.

UnitedHealth's stock price has barely increased over the past five years, gaining just 3.3%, while the company consistently raised its dividend annually, now paying $9.28 per share annually. Despite a tough 2025 with rising medical costs and a signif...

Company Fundamentals
Neutral
4 hours ago
Bitcoin holds steady near $84K amid rising Treasury yields and oil price shifts, with $3B inflows to spot ETFs.

Bitcoin holds steady near $84K amid rising Treasury yields and oil price shifts, with $3B inflows to spot ETFs.

Bitcoin traded around $84,000, up 0.9% on the day but down 2% for the week, maintaining a stable range despite external pressures from rising 10-year Treasury yields hitting multi-year highs and fluctuating oil prices. Spot Bitcoin ETFs have seen eig...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App